Glen Harbor Capital Management’s Quest Diagnostics DGX Stock Holding History

Glen Harbor Capital Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$8.81M	Buy	82,320 +7,924	+11%	+$813K	0.18%	112
2019 Q2	$7.57M	Sell	74,396 -7,504	-9%	-$721K	0.16%	141
2019 Q1	$7.36M	Buy	81,900 +22,232	+37%	+$1.93M	0.16%	134
2018 Q4	$4.97M	Buy	59,668 +16,912	+40%	+$1.59M	0.12%	179
2018 Q3	$4.61M	Sell	42,756 -19,068	-31%	-$2.09M	0.09%	215
2018 Q2	$6.8M	Sell	61,824 -11,452	-16%	-$1.19M	0.15%	145
2018 Q1	$7.35M	Sell	73,276 -7,056	-9%	-$723K	0.17%	128
2017 Q4	$7.91M	Sell	80,332 -25,200	-24%	-$2.39M	0.18%	117
2017 Q3	$9.88M	Sell	105,532 -2,492	-2%	-$265K	0.24%	85
2017 Q2	$12M	Buy	108,024 +49,672	+85%	+$5.25M	0.29%	70
2017 Q1	$5.73M	Sell	58,352 -20,272	-26%	-$1.93M	0.14%	139
2016 Q4	$7.23M	Buy	+78,624	New	+$6.78M	0.2%	95

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MWNA

Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

Glen Harbor Capital Management's DGX Position: Q3 2019 in Review

Glen Harbor Capital Management increased its Quest Diagnostics (DGX) stake by 11% in Q3 2019, buying an estimated $813K and bringing the position to 82,320 shares worth $8.81M. The position accounts for 0.18% of the portfolio, ranked #112.

Glen Harbor Capital Management first reported a position in DGX in Q4 2016 and has held it in 12 quarters since. The position peaked at $12M in Q2 2017. 677 funds tracked by Wall St. Rank hold DGX as of Q3 2019.

Glen Harbor Capital Management held 82,320 shares of Quest Diagnostics worth $8.81M as of Q3 2019.
Glen Harbor Capital Management bought 7,924 Quest Diagnostics shares in Q3 2019, an estimated $813K.
Quest Diagnostics made up 0.18% of Glen Harbor Capital Management's portfolio in Q3 2019, its #112 holding.
Glen Harbor Capital Management first reported a position in Quest Diagnostics in Q4 2016 and has held it in 12 quarters since.
Glen Harbor Capital Management's Quest Diagnostics position peaked at $12M in Q2 2017.
677 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2019.

Based on Glen Harbor Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.